rolafagrel has been researched along with Lupus Nephritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barsotti, P; Ferrario, R; Ferrario, RG; Lamberti, E; Patrono, C; Pugliese, F; Salvati, P; Scampini, G | 1 |
1 trial(s) available for rolafagrel and Lupus Nephritis
| Article | Year |
|---|---|
Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis.
Topics: Animals; Cyclophosphamide; Disease Models, Animal; Female; Fluorescent Antibody Technique; Glomerular Filtration Rate; Imidazoles; Lupus Nephritis; Mice; Mice, Inbred NZB; Naphthalenes; Proteinuria; Survival Rate; Thromboxane B2; Thromboxane-A Synthase | 1995 |